For the plasmacytoid subtype (a rare discohesive tumor with a CDH1 mutation), data are limited, but small studies also find relatively high HER2 expression (up to 83% with positive/borderline status in one series of six cases by Kim et al. [8]). Here, ERBB2 is linked to neoplasm.